Top news in dermatology: At-home hair growth therapy

Deanne Mraz Robinson, MD
Deanne Mraz Robinson

In the top story from last week, Deanne Mraz Robinson, MD, describes how at-home therapy, such as LED light therapy along with in-office platelet-rich plasma injections, helps to prevent further hair loss and protect the hair growth already achieved.

Additionally, an oral Janus kinase (JAK) inhibitor achieved a 50% relative reduction in Severity of Alopecia Tool score at 24 weeks, from data presented at European Academy of Dermatology and Venereology Congress.

Continue reading for the top three dermatology stories from last week.

 

 

At-home therapy plus in-office treatment maximizes hair growth investment

by Deanne Mraz Robinson, MD

Platelet-rich plasma and hair transplant represent a significant financial investment. So, when patients agree to these pricey out-of-pocket procedures, I suggest that they consider layering on at-home therapy, as well. Read more

 

Oral JAK inhibitor improves alopecia areata severity

James Cassella
James V. Cassella

“I believe we are seeing the strongest effect of a JAK inhibitor on alopecia areata reported to date, based on the magnitude of effect that we see and the time courses of these doses,” James V. Cassella, PhD, study author and chief development officer at Concert Pharmaceuticals, told Healio Dermatology. Read more

 

Tralokinumab may neutralize interleukin -13 levels in atopic dermatitis

“We looked at the skin transcriptome in patients with atopic dermatitis and compared that transcriptome to that of healthy control individuals and patients with psoriasis,” study researcher Stephan Weidinger, MD, of the department of dermatology and allergy at University Hospital Schleswig-Holstein in Kiel, Germany, told Healio Dermatology. Read more

 

 

 

Deanne Mraz Robinson, MD
Deanne Mraz Robinson

In the top story from last week, Deanne Mraz Robinson, MD, describes how at-home therapy, such as LED light therapy along with in-office platelet-rich plasma injections, helps to prevent further hair loss and protect the hair growth already achieved.

Additionally, an oral Janus kinase (JAK) inhibitor achieved a 50% relative reduction in Severity of Alopecia Tool score at 24 weeks, from data presented at European Academy of Dermatology and Venereology Congress.

Continue reading for the top three dermatology stories from last week.

 

 

At-home therapy plus in-office treatment maximizes hair growth investment

by Deanne Mraz Robinson, MD

Platelet-rich plasma and hair transplant represent a significant financial investment. So, when patients agree to these pricey out-of-pocket procedures, I suggest that they consider layering on at-home therapy, as well. Read more

 

Oral JAK inhibitor improves alopecia areata severity

James Cassella
James V. Cassella

“I believe we are seeing the strongest effect of a JAK inhibitor on alopecia areata reported to date, based on the magnitude of effect that we see and the time courses of these doses,” James V. Cassella, PhD, study author and chief development officer at Concert Pharmaceuticals, told Healio Dermatology. Read more

 

Tralokinumab may neutralize interleukin -13 levels in atopic dermatitis

“We looked at the skin transcriptome in patients with atopic dermatitis and compared that transcriptome to that of healthy control individuals and patients with psoriasis,” study researcher Stephan Weidinger, MD, of the department of dermatology and allergy at University Hospital Schleswig-Holstein in Kiel, Germany, told Healio Dermatology. Read more